SOX2 and colorectal cancer: We next assessed the SOX2's effect on cell migration and invasion using an established stable SW620 colorectal cancer cells expressing shRNA-SOX2 (SW620shRNA-SOX2) using transwell migration and invasion assays (Corning Inc., USA).